8,9-Dihydrocannabidiol (H2CBD) is a synthetic cannabinoid that is closely related to cannabidiol (CBD) itself. It was shown to have anti-seizure activity essentially identical to that of CBD in tests with rats. It may have certain advantages over CBD, in that it is fully synthetic, inexpensive to produce, and it is not a scheduled drug (cannabis extracts are controlled substances in most parts of the world). In addition, there is no path to synthesize the psychoactive substance tetrahydrocannabinol (THC) from H2CBD. CBD has been shown to convert to some extent to THC in the gastric tract, and the deliberate laboratory conversion of CBD to THC is simple. H2CBD has therefore been studied for its potential use as an alternative to CBD in terms of its lack of abuse liability and absence of psy